Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content and blocking access to the study details. This is an access issue rather than an update to core page content such as the study description or eligibility criteria.SummaryDifference19%

- Check27 days agoChange DetectedThe study's conditions section no longer lists Cystic Fibrosis, and the related topics/MedlinePlus Genetics references have been removed, altering the contextual information and available educational links for readers.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now includes 'Cystic fibrosis' as a related topic and adds MedlinePlus Genetics to the related topics. This expands the background resources available for users reviewing the study record.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded a 2014 U.S. NIH grant/contract note to the study identifiers and updated the page revision to v3.6.6 (replacing the previous v3.6.5).SummaryDifference0.1%

- Check48 days agoChange DetectedThe page no longer shows the 'Cystic Fibrosis' condition and the 'MedlinePlus related topics' section, altering how the study's target conditions and related educational resources are presented.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded Cystic fibrosis to the related topics and introduced a MedlinePlus Genetics link in the related topics section. This provides quick access to genetics resources related to CF on the study page.SummaryDifference0.2%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.